Ipilimumab/nivolumabInsulin dependent diabetes mellitus: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1938卷 / 1期

关键词：

D O I：

10.1007/s40278-023-30900-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：759 / 759

相关论文

共 50 条

[21] TacrolimusPost transplant diabetes mellitus: 2 case reports
Reactions Weekly, 2023, 1954 (1) : 401 - 401
[22] AntineoplasticsLack of efficacy and diabetes mellitus: 2 case reports
Reactions Weekly, 2022, 1916 (1) : 44 - 44
[23] TacrolimusType 1 diabetes mellitus: 2 case reports
Reactions Weekly, 2006, 1113 (1) : 17 - 17
[24] RisperidoneFirst report of diabetes mellitus: 2 case reports
Reactions Weekly, 2001, 873 (1) : 10 - 11
[25] AripiprazoleType 2 diabetes mellitus and constipation: 2 case reports
Reactions Weekly, 2020, 1792 (1) : 38 - 38
[26] Ipilimumab/nivolumabType 1 diabetes mellitus: case report
Reactions Weekly, 2024, 2037 (1) : 221 - 221
[27] Ipilimumab/nivolumabType 1 diabetes mellitus: case report
Reactions Weekly, 2019, 1765 (1) : 203 - 203
[28] Ipilimumab/pembrolizumabHepatitis: 2 case reports
Reactions Weekly, 2017, 1673 (1) : 217 - 217
[29] Ipilimumab/pembrolizumabHypophysitis: 2 case reports
Reactions Weekly, 2022, 1913 (1) : 268 - 268
[30] Ipilimumab/nivolumabNeurotoxicity: 2 case reports
Reactions Weekly, 2023, 1965 (1) : 261 - 261

← 1 2 3 4 5 →